
Ingenza Stock
Industrial biotechnology company
Sign up today and learn more about Ingenza Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Ingenza Stock
Ingenza was founded in 2002, a spin-out company from the University of Edinburgh that was based on the modification and commercialisation of microbial production technologies aimed at improving yields of unnatural amino acids and amines. Since its inception, Ingenza has remained strongly committed to the continuous development and integration of innovative technologies in its core competencies of molecular biology, gene expression, directed evolution, fermentation and process development. Ingenza is a world leader in the application of industrial biotechnology and synthetic biology, providing efficient, scalable bioprocesses for the manufacture of chemicals, biologics, pharmaceuticals and biofuels, from sustainable sources.
Funding History
August 2016 | $50K |
---|
Management
Managing Director
Ian Fotheringham
Co-Founder and Chief Executive Officer
Sinil Srivastava
COO
Jaymin Amin
Press
marketscreener - Aug, 18 2023
Neurocrine Biosciences' Ingrezza Gets FDA Approvalseekingalpha - Jul, 7 2023
BMO upgrades Neurocrine to market perform on Ingrezza outlooknews-medical - Apr, 4 2023
Ingenza appoints Steve Jones as its new Chief Financial Officerpharmiweb - Mar, 24 2023
Ingenza celebrates 20 years of innovationnews-medical - Feb, 26 2023
Ingenza appoints new Strategic Business Advisornews-medical - Jan, 24 2023
Ingenza collaborates with Amplifica to advance novel alopecia treatmentsnews-medical - Feb, 2 2022
Ingenza collaborates with Johnson Matthey for efficient industrial enzyme synthesispharmiweb - Aug, 20 2020
Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technologyfree-press-release - Feb, 14 2018
Ingenza embarks on ConBioChem collaborationEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase